These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 35198565)
21. M6A Classification Combined With Tumor Microenvironment Immune Characteristics Analysis of Bladder Cancer. Zhu H; Jia X; Wang Y; Song Z; Wang N; Yang Y; Shi X Front Oncol; 2021; 11():714267. PubMed ID: 34604051 [TBL] [Abstract][Full Text] [Related]
22. m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma. Zhou D; Wang Y; Wei W; Zhou W; Gu J; Kong Y; Yang Q; Wu Y J Cancer Res Clin Oncol; 2023 Jul; 149(7):3661-3680. PubMed ID: 35972694 [TBL] [Abstract][Full Text] [Related]
23. m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment. Liu F; Yu X; He G J Oncol; 2021; 2021():9987376. PubMed ID: 34745261 [TBL] [Abstract][Full Text] [Related]
24. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma. Liu Z; He J; Han J; Yang J; Liao W; Chen N Front Immunol; 2021; 12():762243. PubMed ID: 35069534 [TBL] [Abstract][Full Text] [Related]
25. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma. Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424 [TBL] [Abstract][Full Text] [Related]
26. m Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720 [TBL] [Abstract][Full Text] [Related]
27. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma. Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578 [TBL] [Abstract][Full Text] [Related]
28. Identification of prognostic m6A modification patterns and score system in melanoma patients. Wang F; Chen P; Ouyang S; Xiong K; Liu Z; Wang Y Medicine (Baltimore); 2024 Apr; 103(17):e37950. PubMed ID: 38669381 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer. Peng B; Lin Y; Yi G; Lin M; Xiao Y; Qiu Y; Yao W; Zhou X; Liu Z Sci Rep; 2024 Jul; 14(1):16404. PubMed ID: 39013954 [TBL] [Abstract][Full Text] [Related]
30. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J Front Genet; 2021; 12():752025. PubMed ID: 35046996 [No Abstract] [Full Text] [Related]
31. M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy. Zhao K; Wei B; Zhang Y; Shi W; Zhang G; Wang Z Front Pharmacol; 2022; 13():1052177. PubMed ID: 36438800 [No Abstract] [Full Text] [Related]
32. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation. Quan Y; Zhang X; Ping H Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837 [TBL] [Abstract][Full Text] [Related]
33. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma. Huang ZD; Lin LL; Liu ZZ; Hu C; Gu HY; Wei RX Front Immunol; 2021; 12():765723. PubMed ID: 35003079 [TBL] [Abstract][Full Text] [Related]
34. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma. Meijing Z; Tianhang L; Biao Y Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200 [No Abstract] [Full Text] [Related]
35. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma. Ji J; Liu S; Liang Y; Zheng G BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073 [TBL] [Abstract][Full Text] [Related]
36. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer. Liu X; Ma C; Liu H; Sun Z; Luo J J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010 [TBL] [Abstract][Full Text] [Related]
37. m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia. Xu ZJ; Wen XM; Zhang YC; Jin Y; Ma JC; Gu Y; Chen XY; Xia PH; Qian W; Lin J; Qian J Front Genet; 2022; 13():948079. PubMed ID: 36035161 [TBL] [Abstract][Full Text] [Related]
38. Novel RNA N6-methyladenosine regulator related signature for predicting clinical and immunological characteristics in breast cancer. Zhang J; Liu G; Dai Z; Xie F; Zheng R; Yuan B; Guo L Gene; 2023 Feb; 853():147095. PubMed ID: 36464173 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy. Liu Z; Zhong J; Zeng J; Duan X; Lu J; Sun X; Liu Q; Liang Y; Lin Z; Zhong W; Wu W; Cai C; Zeng G Front Immunol; 2021; 12():735170. PubMed ID: 34531875 [TBL] [Abstract][Full Text] [Related]
40. Characterization of m6A methylation modifications in gastric cancer. Yin W; Huo Z; Zuo J; Wang H; Chen B; Zhou L Aging (Albany NY); 2024 Jan; 16(1):89-105. PubMed ID: 38206646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]